Detailed answers about NORTHERN PHARMACIES LIMITED, including incorporation, status, business activity, and accounts information.
When was NORTHERN PHARMACIES LIMITED founded?
NORTHERN PHARMACIES LIMITED was officially incorporated on 3 March 1969 and is registered under company number NI007549. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NORTHERN PHARMACIES LIMITED?
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of NORTHERN PHARMACIES LIMITED?
NORTHERN PHARMACIES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NORTHERN PHARMACIES LIMITED do?
NORTHERN PHARMACIES LIMITED operates in the following sector: 47730 - Dispensing chemist in specialised stores. This provides insight into the company's primary business activity and industry focus.
What is NORTHERN PHARMACIES LIMITED's registered address?
The registered office address of NORTHERN PHARMACIES LIMITED is 5 ANNADALE AVENUE, BELFAST, BT7 3JH. This is the official address filed with Companies House for legal and statutory correspondence.
Is NORTHERN PHARMACIES LIMITED financially stable?
The most recent accounts for NORTHERN PHARMACIES LIMITED were made up to 31 March 2025, filed as SMALL. Next accounts are due by 31 December 2026.
Does NORTHERN PHARMACIES LIMITED have any charges or mortgages?
NORTHERN PHARMACIES LIMITED has 3 registered charges, of which 3 are outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.